APSR logo
Asian 
Pacific 
Society of 
Respirology
APSR logo

Previous ESAP
ESAP logo

Next ESAP

ESAP

Indonesia

Bali
13 November 2014

Updates on Lung Cancer

With the assistance of the APSR Lung Cancer Assembly, and the hosted by the Indonesian Society of Respirology, this pre-congress ESAP took place in Bali, Indonesia, as a post-graduate course prior to the 19th Congress of the APSR.

Objectives:

Lung cancer is the leading cause of mortality of all cancer in the world. As two-thirds of smoking prevalence in the world is in the Asia-Pacific region, especially China, India and Indonesia, the prevalence of lung cancer in the region is increasing. The prevalence of lung cancer for nonsmokers and females is also increasing.

Pulmonologists and respiratory physicians play a key role in the diagnosis, staging and treatment of lung cancer. They also lead and participate in multidisciplinary efforts for lung cancer as well as managing comorbidities, provide medical treatment (chemotherapy and biological therapy), endobronchial treatment, general supportive care, and end-of-life care.

As the advancement of lung cancer biology and treatments is challenging, it is important to educate pulmonologists in the field. This ESAP presented updates on lung cancer biology, diagnosis and treatment.

Chairs:

Chair:Dr Kwun Fong
Professor
University of Queensland
Thoracic Research Centre at The Prince Charles Hospital
Australia
Co-chair: Dr Anwar Jusuf
Professor
Department of Pulmonology and Respiratory Medicine
Faculty of Medicine,
University of Indonesia Persahabatan Hospital,


Jakarta,
Indonesia

Speakers:

  • Dr E Hiyama (Japan)
  • Dr T Kikuchi (Japan)
  • Dr K Kishi (Japan)
  • Dr C Bai (China)
  • Dr D C L Lam (Hong Kong)
  • Dr B Robinson (Australia)
  • Dr C K Liam (Malaysia)
  • Dr K Hagiwara (Japan).

Attendees:

The event was well attended, including respiratory physicians, healthcare professionals and researchers from Australia, China, Hong Kong, Indonesia, Japan, Korea, Malaysia, Philipines, Singapore, and United Arab Emirates.

Programme

09.00–09.10Course introduction
Kwun Fong
09.10–09.35Molecular diagnosis of lung cancer
Eiso Hiyama
09.35–10.00Lung cancer stem cell
Toshiaki Kikuchi
10.00–10.25Thoracic CT pattern in lung cancer: correlate on of CT and pathological diagnosis
Kazuma Kishi
10.25–10.30Discussion
10.30–11.00Break
11.00–11.25Genetic heterogeneity in lung cancer
Koichi Hagiwara
11.25–11.50The TNM staging system for lung cancer
Kwun Fong
11.50–12.00Discussion
12.00–13.00Lunch
13.00–13.10Summary of morning session
Kwun Fong
13.10–13.35Targeted agent in lung cancer: EGFR TKI and beyond
David CL Lam
13.35–14.00Lung tumour immunology
Bruce Robinson
14.00–14.25Neuroendocrine tumors of the lung
Chong-Kin Liam
14.25–14.35Discussion
14.35–15.00Break
15.00–15.25SCLC: what we have now
Chunxue Bai
15.25–15.50Lung cancer: the future ahead
Koichi Hagiwara
15.50–16.00Closing Postgraduate Course
Kwun Fong